116 related articles for article (PubMed ID: 8920658)
21. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins.
Hinds PW; Mittnacht S; Dulic V; Arnold A; Reed SI; Weinberg RA
Cell; 1992 Sep; 70(6):993-1006. PubMed ID: 1388095
[TBL] [Abstract][Full Text] [Related]
22. Reverse mutational analysis reveals threonine-373 as a potentially sufficient phosphorylation site for inactivation of the retinoblastoma tumor suppressor protein (pRB).
Lents NH; Gorges LL; Baldassare JJ
Cell Cycle; 2006 Aug; 5(15):1699-707. PubMed ID: 16880741
[TBL] [Abstract][Full Text] [Related]
23. Functional ablation of pRb activates Cdk2 and causes antiestrogen resistance in human breast cancer cells.
Varma H; Skildum AJ; Conrad SE
PLoS One; 2007 Dec; 2(12):e1256. PubMed ID: 18060053
[TBL] [Abstract][Full Text] [Related]
24. Collective inhibition of pRB family proteins by phosphorylation in cells with p16INK4a loss or cyclin E overexpression.
Ashizawa S; Nishizawa H; Yamada M; Higashi H; Kondo T; Ozawa H; Kakita A; Hatakeyama M
J Biol Chem; 2001 Apr; 276(14):11362-70. PubMed ID: 11152455
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II and serum differentially regulate expression of cyclins, activity of cyclin-dependent kinases, and phosphorylation of retinoblastoma gene product in neonatal cardiac myocytes.
Sadoshima J; Aoki H; Izumo S
Circ Res; 1997 Feb; 80(2):228-41. PubMed ID: 9012745
[TBL] [Abstract][Full Text] [Related]
26. Human pituitary adenomas infrequently contain inactivation of retinoblastoma 1 gene and activation of cyclin dependent kinase 4 gene.
Honda S; Tanaka-Kosugi C; Yamada S; Sano T; Matsumoto T; Itakura M; Yoshimoto K
Endocr J; 2003 Jun; 50(3):309-18. PubMed ID: 12940460
[TBL] [Abstract][Full Text] [Related]
27. Multiple abnormalities of the p16INK4a-pRb regulatory pathway in cultured melanoma cells.
Rizos H; Darmanian AP; Indsto JO; Shannon JA; Kefford RF; Mann GJ
Melanoma Res; 1999 Feb; 9(1):10-9. PubMed ID: 10338330
[TBL] [Abstract][Full Text] [Related]
28. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia.
Cordon-Cardo C
Am J Pathol; 1995 Sep; 147(3):545-60. PubMed ID: 7677168
[TBL] [Abstract][Full Text] [Related]
29. Early and Late G1/S Cyclins and Cdks Act Complementarily to Enhance Authentic Human β-Cell Proliferation and Expansion.
Tiwari S; Roel C; Wills R; Casinelli G; Tanwir M; Takane KK; Fiaschi-Taesch NM
Diabetes; 2015 Oct; 64(10):3485-98. PubMed ID: 26159177
[TBL] [Abstract][Full Text] [Related]
30. Aberrant nucleocytoplasmic localization of the retinoblastoma tumor suppressor protein in human cancer correlates with moderate/poor tumor differentiation.
Jiao W; Lin HM; Datta J; Braunschweig T; Chung JY; Hewitt SM; Rane SG
Oncogene; 2008 May; 27(22):3156-64. PubMed ID: 18071317
[TBL] [Abstract][Full Text] [Related]
31. Insulin receptor substrate-4 is overexpressed in colorectal cancer and promotes retinoblastoma-cyclin-dependent kinase activation.
Sanmartín-Salinas P; Lobo MDVT; Noguerales-Fraguas F; Londoño MT; Jiménez-Ruiz A; Guijarro LG
J Gastroenterol; 2018 Aug; 53(8):932-944. PubMed ID: 29353348
[TBL] [Abstract][Full Text] [Related]
32. Cyclin-dependent kinase inhibitors: novel anticancer agents.
Mani S; Wang C; Wu K; Francis R; Pestell R
Expert Opin Investig Drugs; 2000 Aug; 9(8):1849-70. PubMed ID: 11060782
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Smad antiproliferative function by CDK phosphorylation.
Liu F; Matsuura I
Cell Cycle; 2005 Jan; 4(1):63-6. PubMed ID: 15611645
[TBL] [Abstract][Full Text] [Related]
34. Discovery of a regulatory motif that controls the exposure of specific upstream cyclin-dependent kinase sites that determine both conformation and growth suppressing activity of pRb.
Driscoll B; T'Ang A; Hu YH; Yan CL; Fu Y; Luo Y; Wu KJ; Wen S; Shi XH; Barsky L; Weinberg K; Murphree AL; Fung YK
J Biol Chem; 1999 Apr; 274(14):9463-71. PubMed ID: 10092628
[TBL] [Abstract][Full Text] [Related]
35. Cyclin D activates the Rb tumor suppressor by mono-phosphorylation.
Narasimha AM; Kaulich M; Shapiro GS; Choi YJ; Sicinski P; Dowdy SF
Elife; 2014 Jun; 3():. PubMed ID: 24876129
[TBL] [Abstract][Full Text] [Related]
36. Emodin-8-O-β-D-glucopyranoside, a natural hydroxyanthraquinone glycoside from plant, suppresses cancer cell proliferation via p21-CDKs-Rb axis.
Li Y; Li K; Zhao Y; Li Y; Li D; Shen L; Wang Q; Yang HS; Sun Z
Toxicol Appl Pharmacol; 2022 Mar; 438():115909. PubMed ID: 35134436
[TBL] [Abstract][Full Text] [Related]
37. Aberrant expression of pRb and p16(INK4), alone or in combination, indicates poor outcome after resection in patients with colorectal carcinoma.
Cui X; Shirai Y; Wakai T; Yokoyama N; Hirano S; Hatakeyama K
Hum Pathol; 2004 Oct; 35(10):1189-95. PubMed ID: 15492985
[TBL] [Abstract][Full Text] [Related]
38. Cyclin D and retinoblastoma gene product expression in actinic keratosis and cutaneous squamous cell carcinoma in relation to p53 expression.
Bito T; Ueda M; Ahmed NU; Nagano T; Ichihashi M
J Cutan Pathol; 1995 Oct; 22(5):427-34. PubMed ID: 8594075
[TBL] [Abstract][Full Text] [Related]
39. Role of the retinoblastoma protein in the pathogenesis of human cancer.
Sellers WR; Kaelin WG
J Clin Oncol; 1997 Nov; 15(11):3301-12. PubMed ID: 9363859
[TBL] [Abstract][Full Text] [Related]
40. Loss of functional pRB is not a ubiquitous feature of B-cell malignancies.
Sinclair AJ; Frost V
Br J Cancer; 1999 May; 80(5-6):670-5. PubMed ID: 10360642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
